Results 131 to 140 of about 56,405 (189)

Initial characterization of M₂-muscarinic receptor overexpressing mouse heart. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Gergs U, Buchwalow IB, Hofmann B, Myslivecek J, Janisova K, Hadova K, Schettler F, Keller M, Klimas J, Neumann J.   +9 more
europepmc   +1 more source

Striatal M₄ muscarinic receptors determine the biological rhythm of activity, with a supportive role of M₁ muscarinic receptors. [PDF]

Front Pharmacol
Janisova K, Uhlirova M, Forczek S, Myslivecek J.   +3 more
europepmc   +1 more source

The pharmacology underlying the unique antipsychotic efficacy of clozapine. [PDF]

J Psychopharmacol
Reynolds GP.
europepmc   +1 more source

New Pharmacological Treatment Approaches for Schizophrenia: Navigating the Post-iclepertin Landscape. [PDF]

CNS Drugs
Englisch S, Zink M.
europepmc   +1 more source

FF/UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up from Dual Therapy Stratified by Exacerbations and Prior Dual Therapy: A Subgroup Analysis of a Comparative Effectiveness Study. [PDF]

Adv Ther
Wedzicha JA, Noorduyn SG, Di Boscio V, Le Rouzic O, Majumdar A, Paczkowski R, Weng S, Germain G, Laliberté F, Mannino D.   +9 more
europepmc   +1 more source

Synergistic mechanisms of medullary cholinergic-serotonergic pathway interactions in regulating neuronal excitability and locomotor activities. [PDF]

Commun Biol
Cheng Y, Dai Y, Ge R, Zhang Q.
europepmc   +1 more source

Discovery of VU6025733 (AG06827): A Highly Selective, Orally Bioavailable, and Structurally Distinct M₄ Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) with Robust <i>In Vivo</i> Efficacy. [PDF]

ACS Chem Neurosci
Gregro AR, Park C, Long MF, Baker LA, Bollinger KA, Ringuette AE, Peng L, Luscombe VB, Billard NB, Rodriguez AL, Niswender CM, Peng W, Dickerson JW, Rook JM, O'Neill J, Chang S, Boonen HCM, Jensen T, Thomsen MS, Bridges TM, Boutaud O, Conn PJ, Engers DW, Lindsley CW, Temple KJ.   +24 more
europepmc   +1 more source